GLP-1 receptor agonists have redefined what is possible in physician-led weight loss, but their power comes with responsibility. Dr. Don Gates of Savannah, the physician at Scale Solutions in Savannah, Georgia, is among the most experienced voices in coastal Georgia on the appropriate clinical management of patients using these medications. In this article, Dr. Gates shares the monitoring standards and protocols that Scale Solutions follows to keep patients safe and results optimized.
Why GLP-1 Monitoring Matters: Dr. Don Gates of Savannah Explains the Stakes
GLP-1 receptor agonists — a class that includes semaglutide and tirzepatide — work by mimicking the glucagon-like peptide-1 hormone produced naturally in the gut after eating. They suppress appetite, slow gastric emptying, and improve insulin sensitivity. These mechanisms produce meaningful weight loss, but they also interact with metabolic systems in ways that require clinical oversight.
“These are not vitamins,” says Dr. Don Gates of Savannah. “They are pharmaceutical agents with real effects on the gastrointestinal system, the pancreas, and metabolic function. When they are prescribed and monitored correctly, they are among the most effective tools in obesity medicine. When they are prescribed carelessly, patients can be harmed.” This perspective is why Scale Solutions’ GLP-1 protocols include comprehensive pre-treatment screening and regular monitoring throughout the course of therapy.
Patients considering GLP-1 therapy can find additional educational resources at Scale Solutions’ coastal Georgia GLP-1 news page, which Dr. Gates and his team keep current with evidence-based updates.
Pre-Treatment Screening: What Dr. Don Gates of Savannah Reviews Before Prescribing
Before any GLP-1 medication is prescribed at Scale Solutions in Savannah, Georgia, patients undergo a structured pre-treatment evaluation that includes:
- Personal and family history review — Screening for personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2, which are contraindications for GLP-1 agonist use as noted in FDA prescribing guidelines.
- Pancreatic history assessment — Review of any personal history of pancreatitis, which warrants careful consideration before GLP-1 initiation.
- Gastrointestinal history — Assessment of gastroparesis or other significant GI conditions that may be worsened by the gastric-emptying effects of these medications.
- Baseline laboratory panel — Including HbA1c, fasting glucose, comprehensive metabolic panel, lipid profile, and liver function tests.
- Medication interaction review — GLP-1 agents can affect the absorption and timing of other medications, particularly oral diabetes treatments, necessitating a thorough medication reconciliation.
This pre-treatment process reflects the standard of care established by the American Association of Clinical Endocrinologists and the Obesity Medicine Association, both of which have published clinical guidance on GLP-1 prescribing practices.
Dosing Protocols at Scale Solutions Under Dr. Don Gates of Savannah
Dose escalation is one of the most important aspects of GLP-1 management. Starting patients at too high a dose increases the likelihood of nausea, vomiting, and gastrointestinal discomfort — side effects that are among the most common reasons patients discontinue these medications. The clinical trials for semaglutide used a structured dose-escalation schedule over 16 to 20 weeks, a protocol that Dr. Don Gates of Savannah follows at Scale Solutions.
“The escalation schedule exists for a reason,” Dr. Gates explains. “Going too fast creates unnecessary discomfort and may lead patients to give up on a medication that, if tolerated properly, could significantly improve their health.” Patients at Scale Solutions receive clear instructions on dosing, timing, administration technique, and what to do if they experience side effects.
Ongoing Laboratory Monitoring Under Dr. Don Gates’ Protocols
After GLP-1 therapy begins, Scale Solutions conducts regular laboratory re-checks to monitor for potential complications and assess treatment response. Dr. Don Gates of Savannah typically schedules these at 12-week intervals for stable patients, with more frequent monitoring for those with comorbid conditions such as type 2 diabetes, where medication adjustments may be needed as weight and blood glucose levels change.
Key parameters tracked during ongoing monitoring include:
- HbA1c and fasting glucose (particularly important in patients with diabetes or prediabetes)
- Renal function (serum creatinine, eGFR), as dehydration from reduced appetite can affect kidney function
- Liver function tests for patients on hepatotoxic medications
- Electrolytes, given potential for reduced fluid intake
- Lipid panel reassessment at 6-month intervals
A study in Diabetes Care highlighted the importance of regular metabolic monitoring in patients on GLP-1 therapy, particularly those with pre-existing diabetes, noting that glucose-lowering effects often exceed expectations and require medication adjustments to prevent hypoglycemia in patients on concurrent insulin or sulfonylureas.
Medication Quality and Pharmacy Standards at Scale Solutions
A critical but sometimes overlooked dimension of GLP-1 safety is medication quality. The significant demand for these medications has led to the proliferation of unregulated sources and compounded formulations of uncertain purity and dosing accuracy. Dr. Don Gates of Savannah has a firm policy at Scale Solutions: all medications are sourced exclusively through licensed, accredited pharmacies.
“I am not willing to compromise on medication quality,” Dr. Gates states. “A patient trusts me with their health, and that trust begins with knowing that what I prescribe is exactly what it claims to be.” This standard protects patients from the risks associated with medications of unknown provenance, a concern that the FDA has flagged publicly in consumer advisories regarding compounded semaglutide products.
Patients can find more information on GLP-1 safety standards through Scale Solutions’ GLP-1 resource page.
What Patients Can Do to Support Their Own Monitoring Success
Effective monitoring is a partnership. Dr. Don Gates of Savannah emphasizes to patients that their role in the process is as important as the physician’s. Patients are encouraged to keep scheduled appointments, report side effects promptly rather than waiting for a check-in, maintain hydration, and communicate honestly about dietary adherence and medication compliance.
Scale Solutions in Savannah, Georgia provides patients with clear written guidance on what to watch for and when to call. The practice’s team is reachable at (912) 352-7546, and patients are encouraged to contact the office whenever they have questions rather than seeking answers from unvetted online sources.
Frequently Asked Questions
What qualifies Dr. Don Gates of Savannah to manage GLP-1 therapy?
Dr. Don Gates of Savannah has been practicing bariatric and medical weight loss medicine since 1999, trained at Loma Linda University, and has extensive clinical experience managing patients on a wide range of obesity medications including GLP-1 receptor agonists.
How often will I need lab work while on GLP-1 medication at Scale Solutions?
Dr. Don Gates typically schedules laboratory monitoring every 12 weeks for stable patients, with more frequent checks for those with diabetes, kidney conditions, or other metabolic comorbidities that require closer clinical attention.
What side effects should I report to Scale Solutions right away?
Patients should call (912) 352-7546 promptly if they experience severe abdominal pain, persistent vomiting, signs of pancreatitis, significant changes in vision, or symptoms of severe hypoglycemia. Less urgent but still reportable side effects include persistent nausea, constipation, or significant appetite changes.
Where does Scale Solutions source its GLP-1 medications?
Scale Solutions sources all medications exclusively through licensed, accredited pharmacies. Dr. Don Gates of Savannah maintains strict pharmacy standards as a patient safety measure.
Can I start GLP-1 therapy at Scale Solutions if I have previously tried it elsewhere?
Yes. Dr. Don Gates conducts a comprehensive evaluation that takes prior medication history into account. Patients who have tried GLP-1 therapy before are welcome, and the team will assess what adjustments or additions to the plan may optimize outcomes this time.
Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. GLP-1 medications are prescription agents that require physician evaluation and ongoing monitoring. Consult a licensed physician before beginning any medication regimen.
If you are considering GLP-1 therapy in coastal Georgia, trust your care to Dr. Don Gates of Savannah and the Scale Solutions team. We adhere to strict clinical protocols, work only with licensed, accredited pharmacies, and monitor every patient’s progress with care and precision. Call (912) 352-7546, email info@scale-solutions.com, or book a consultation today. Serving Savannah, Pooler, and Hinesville, Georgia.
Frequently Asked Questions
What qualifies Dr. Don Gates of Savannah to manage GLP-1 therapy?
Dr. Don Gates of Savannah has been practicing bariatric and medical weight loss medicine since 1999, trained at Loma Linda University, and has extensive clinical experience managing patients on a wide range of obesity medications including GLP-1 receptor agonists.
How often will I need lab work while on GLP-1 medication at Scale Solutions?
Dr. Don Gates typically schedules laboratory monitoring every 12 weeks for stable patients, with more frequent checks for those with diabetes, kidney conditions, or other metabolic comorbidities that require closer clinical attention.
What side effects should I report to Scale Solutions right away?
Patients should call (912) 352-7546 promptly if they experience severe abdominal pain, persistent vomiting, signs of pancreatitis, significant changes in vision, or symptoms of severe hypoglycemia. Less urgent but still reportable side effects include persistent nausea, constipation, or significant appetite changes.
Where does Scale Solutions source its GLP-1 medications?
Scale Solutions sources all medications exclusively through licensed, accredited pharmacies. Dr. Don Gates of Savannah maintains strict pharmacy standards as a patient safety measure.
Can I start GLP-1 therapy at Scale Solutions if I have previously tried it elsewhere?
Yes. Dr. Don Gates conducts a comprehensive evaluation that takes prior medication history into account. Patients who have tried GLP-1 therapy before are welcome, and the team will assess what adjustments or additions to the plan may optimize outcomes this time.
About the Physician
Dr. Donald L. Gates, MD
Dr. Don Gates is a Loma Linda-trained physician practicing bariatric medicine in coastal Georgia since 1999. He leads Scale Solutions Medical Weight Loss, with offices in Savannah, Pooler, and Hinesville, GA. He provides physician-supervised GLP-1 therapy — including semaglutide and tirzepatide — paired with personalized nutrition and metabolic guidance. Spanish-speaking. Read full bio →
Call to schedule: (912) 352-7546 · Email: info@scale-solutions.com
Ready to work with Dr. Gates?
Bariatric medicine since 1999 — Loma Linda trained, Spanish-speaking, serving Savannah, Pooler, and Hinesville.